Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

pain management

Lucid Diligence Brief - BioPharma

GNI Group Acquires Ayumi Pharmaceutical | Lucid Diligence Brief

GNI Group’s Ayumi acquisition tests Japan commercial scale, Calonal durability,…

by Sreyashi Paul

Public_Health

Public Health Today—April 9, 2026

This weekly Public Health update summarizes recent research, observational…

Public_Health

Public Health Weekly News - August 29th 2025

Public Health Update: Plastic-Free Living, Pig Lung Transplant, Diabetes…

Neuroscience

Neuroscience Weekly News - July 9th 2025

🧠 This Week in Neuroscience: FDA Breakthroughs, CAR-T Advancements, Gene…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
LucidWargames
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Respiratory Today—June 26, 2026
Vaccines Today—June 26, 2026
Public Health Today—June 26, 2026
Cell and Gene Therapy Today—June 25, 2026
Rare Diseases Today—June 25, 2026

Tags

AA Signature AAT deficiency ABBV-932 Abogen Alphabet ANCA-Associated Vasculitis CD19 CD19 CAR-T Cizutamig DeepHealth OS digital twin DMX-200 docetaxel DYNE-251 ELREXFIO Enanta Fertility Benefits GABAB PAM Heart Failure-Associated Oedema HGPS Injectable Semaglutide ISCIB1+ IVUS Kesimpta LGMD2i MSD partnership Myelodysplastic syndromes Novo Medi Sciences Peripheral artery disease Plant-Based Diet predictBBB.ai Prost-LM protocol-based HTN diabetes care Roflumilast Cream Sanfilippo Syndrome Type B sk biopharmaceuticals sleep and brain health Stenoparib SynKIR-110 Terumo Aortic Tobacco policy TVR110 University of Oslo Valerio Therapeutics ViGenCell

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Respiratory Today—June 26, 2026
Vaccines Today—June 26, 2026
Public Health Today—June 26, 2026
Cell and Gene Therapy Today—June 25, 2026
Rare Diseases Today—June 25, 2026

TAGS

AA Signature AAT deficiency ABBV-932 Abogen Alphabet ANCA-Associated Vasculitis CD19 CD19 CAR-T Cizutamig DeepHealth OS digital twin DMX-200 docetaxel DYNE-251 ELREXFIO Enanta Fertility Benefits GABAB PAM Heart Failure-Associated Oedema HGPS Injectable Semaglutide ISCIB1+ IVUS Kesimpta LGMD2i MSD partnership Myelodysplastic syndromes Novo Medi Sciences Peripheral artery disease Plant-Based Diet predictBBB.ai Prost-LM protocol-based HTN diabetes care Roflumilast Cream Sanfilippo Syndrome Type B sk biopharmaceuticals sleep and brain health Stenoparib SynKIR-110 Terumo Aortic Tobacco policy TVR110 University of Oslo Valerio Therapeutics ViGenCell

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy